<?xml version="1.0"?>
<Articles JournalTitle="The Research in Heart Yield and Translational Medicine (RHYTHM)">
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>The Research in Heart Yield and Translational Medicine (RHYTHM)</JournalTitle>
      <Issn>3115-7270</Issn>
      <Volume>1</Volume>
      <Issue>1</Issue>
      <PubDate PubStatus="epublish">
        <Year>2006</Year>
        <Month>04</Month>
        <Day>15</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Surgical Radiofrequency MAZE III Ablation for Treatment of Atrial Fibrillation During Open Heart Surgery</title>
    <FirstPage>23</FirstPage>
    <LastPage>27</LastPage>
    <AuthorList>
      <Author>
        <FirstName></FirstName>
        <LastName>Rezayat Parvizi</LastName>
        <affiliation locale="en_US"></affiliation>
      </Author>
      <Author>
        <FirstName></FirstName>
        <LastName>Fariborz Akbarzadeh</LastName>
        <affiliation locale="en_US"></affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2015</Year>
        <Month>10</Month>
        <Day>03</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Background: Atrial fibrillation is a common arrhythmia in patients with rheumatic mitral and other valve diseases who
are candidates for valve repair surgeries. Conversion of rhythm to sinus has positive effects on quality of life and lower use
of medications. The aim of this clinical study was to evaluate the effectiveness of the radiofrequency ablation Maze III procedure
in the treatment of atrial fibrillation associated with rheumatic heart valve disease.
Methods: We applied a modified Cox III Maze procedure using radiofrequency ablation in the treatment of atrial fibrillation
associated with rheumatic heart valve disease and evaluated the outcome of 20 patients of atrial fibrillation associated
rheumatic valve disease who underwent radiofrequency ablation Maze III procedure plus heart valve surgery. Demographic,
echocardiographic, Electrocardiographic and Doppler study data were calculated before surgery, six month and one year
after surgery..
Results: No perioperative deaths occurred in the study group. Duration of additional time for doing radiofrequency
ablation was about 22 minutes. Freedom from atrial fibrillation was 85% and 75% at six months and one year follow-up
respectively...
Conclusions: The addition of the radiofrequency ablation Maze procedure to heart valve surgery is safe and effective in
the treatment of atrial fibrillation associated with rheumatic heart valve disease..</abstract>
    <web_url>https://rhythm.tums.ac.ir/index.php/jthc/article/view/6</web_url>
    <pdf_url>https://rhythm.tums.ac.ir/index.php/jthc/article/download/6/4</pdf_url>
  </Article>
</Articles>
